Researchers Develop Ascorbyl Palmitate-Based Gold Nanoparticles for Targeted Gemcitabine Delivery in Cancer Treatment

Researchers have developed a novel nanocarrier system using ascorbyl palmitate-based hydrophobic gold nanoparticles for the delivery of gemcitabine, a chemotherapy drug commonly used in cancer treatment. The study outlines the creation and application of these nanoparticles, which aim to improve the efficiency and targeted delivery of gemcitabine to cancer cells.

The research highlights the use of ascorbyl palmitate, a derivative of vitamin C, to create hydrophobic gold nanoparticles capable of encapsulating gemcitabine. The study details how this nanocarrier system enhances the stability and bioavailability of the drug while potentially reducing its side effects. Researchers conducted experiments to evaluate the effectiveness of this delivery method, focusing on its ability to target specific cells and release the drug in a controlled manner. The findings suggest that this approach could offer an alternative strategy for improving chemotherapy treatments by addressing limitations associated with conventional drug delivery systems.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 26, 2025

Related posts:

Health News: Reports Cover Disease Research, Vaccination Updates, and Health Policy Changes Panel Discusses Role of Once-Daily Extended-Release VMAT2 Inhibitors in Tardive Dyskinesia Management Cardiologist Cautions Against Relying on Apple Watch Hypertension Alerts for Public Health Camelid Antibody Engineered to Block ACE2 Receptor and Prevent SARS-CoV-2 Cell Entry

Author

GOAI